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Abstract: Multilayer capsules templated on decomposable vaterite CaCO3 crystals are widely
used as vehicles for drug delivery. The capsule represents typically not a hollow but matrix-like
structure due to polymer diffusion into the porous crystals during multilayer deposition. The capsule
formation mechanism is not well-studied but its understanding is crucial to tune capsule structure
for a proper drug release performance. This study proposes new approach to noninvasively probe
and adjust internal capsule structure. Polymer capsules made of poly(styrene-sulfonate) (PSS)
and poly(diallyldimethylammonium chloride) (PDAD) have been stained with fluorescence dye
rhodamine 6G. Physical-chemical aspects of intermolecular interactions required to validate the
approach and adjust capsule structure are addressed. The capsules consist of a defined shell (typically
0.5–2 µm) and an internal matrix of PSS-PDAD complex (typically 10–40% of a total capsule volume).
An increase of ionic strength and polymer deposition time leads to the thickening of the capsule shell
and formation of a denser internal matrix, respectively. This is explained by effects of a polymer
conformation and limitations in polymer diffusion through the crystal pores. We believe that the
design of the capsules with desired internal structure will allow achieving effective encapsulation
and controlled/programmed release of bioactives for advanced drug delivery applications.
Keywords: layer-by-layer; self-assembly; mesoporous; calcium carbonate; fluorescence
1. Introduction
The layer-by-layer (LbL) assembly of oppositely charges polyelectrolytes is a simple but powerful
method allowing the design of multilayer polymer architectures [1–4]. Typically, this method assumes
the alternating polymer deposition on core materials which can be either flat surfaces [5,6] or
3D structures [2–4]. The LbL coating of sacrificial 3D templates (cores) such as polystyrene [7,8],
melamine formaldehyde [9,10], manganese carbonate [10], and calcium carbonate particles [1,11,12],
includes further removal of the colloidal cores and subsequent formation of the multilayer capsules.
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Such capsules have a polymer shell and inner cavity that may be loaded with various kinds
of therapeutic molecules including hydrophilic and hydrophobic low-molecular weight drugs,
(bio)polymers, proteins and enzymes, hormones, and DNA [13].
The major advantages and the key properties of the vaterite calcium carbonate crystals are
(i) highly developed mesoporous internal structure that offers a large surface for encapsulation of
molecules of interest; (ii) decomposition of these cores at mild conditions using slightly acidic solvents
or chelating agents (e.g., EDTA and citric acid), and (iii) simple, reproducible, and inexpensive
method of crystal synthesis in lab [13]. The capsules templated on the CaCO3 cores have been
successfully applied for various biomedical applications including intracellular and extracellular drug
delivery [14,15] and medical diagnostics [16]. A number of recent works on CaCO3 templated capsules
is devoted to the investigation of drug release performance of the capsules [17–21]. Different release
behavior for the capsules of identical composition but templated on the cores of different nature
(MnCO3 and melamine formaldehyde) revealed that the capsules prepared using different core
materials can be either hollow or filled with an internal polymer matrix present into the capsule
lumen [10]. This depends on the porosity of the cores and ability of polymers to diffuse into the core.
Hollow capsules consist of semipermeable shells and empty internal cavity that can be filled with
encapsulated molecules. The release from such structures is usually limited by the diffusion across
the capsule shell. Instead, matrix-type capsules are filled with a polymer network that can host and
restrain encapsulated molecules and therefore to govern the release of the molecules [22,23].
Modern methods used for the investigation of the internal structure of the capsules are usually
based on imaging technologies and include characterization of capsule mechanical properties using
atomic force microscopy (AFM) [24]; capsule structure using scanning electron microscopy (SEM)
including cryo-SEM [25] and environmental SEM [26] to analyze fully hydrated and chemically
unmodified state of the capsules. However, these methods can be destructive or require drying of the
capsules. Some additional information can also be obtained by probing the capsule permeability using
fluorescent recovery after photobleaching [27].
Herein, we investigate the internal structure of CaCO3-templated multilayer capsules
composed from model synthetic well-studied polymers poly(styrene-sulfonate) and
poly(diallyldimethylammonium chloride) or PSS/PDAD for short. Deposition of PSS/PDAD
multilayers onto the cores of different nature, e.g., polystyrene [28], melamine formaldehyde [29],
calcium phosphate [30], and vaterite particles [31] is widely used for the fabrication of multilayer
PSS/PDAD capsules. Both PDAD and PSS polymers are synthetic; although they may not be easily
biodegradable in blood compositions, these polymers possess negligible cell toxicity when used in
low concentrations suitable for a wide range of biomedical applications. For instance, quantum dots
protected by a layer of PDAD have been shown to have low toxicity and are used for the cell analysis
detection and imaging [32]. Gold nanorods coated with either PSS/PDAD or single PDAD layer have
also negligible effects on cell functions and viability [33]. It also has been reported that PSS/PDAD
nanocapsules do not change the cell culture metabolic conditions as was probed using breast cancer
cells [34].
We present a new approach to identify the capsule structure that is based on the postloading
of preformed capsules with the fluorescent dye, rhodamine 6G (R6G). We focus on analysis of
interpolymer PSS-PDAD interaction and the interactions of the polymers with the dye. This is
investigated via fluorescence characteristics of the dye in the presence of polymers and their complexes.
A way to tune the capsule internal structure by variation of the capsule preparation conditions such as
ionic strength and polymer deposition time is considered. We hope that in future this study will allow
preprogramming the release profile for drug delivery and other biological applications based on the
utilization of the CaCO3-templated capsules.
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2. Materials and Methods
Calcium chloride dehydrate (CaCl2·2H2O), sodium carbonate (Na2CO3), sodium chloride (NaCl),
poly(styrene-sulfonate) (PSS, average MW 70 kDa), poly(diallyldimethylammonium chloride) (PDAD,
molecular weight 200–350 kDa), rhodamine 6G (R6G), and ethylenediaminetetraacetic acid sodium
salt (EDTA) were purchased from Sigma-Aldrich (Seelze, Germany). All chemicals were used without
further purification. TRIS-buffered saline (TBS, 10X), pH 7.4 (J60764), contained 250 mM TRIS, 27 mM
potassium chloride, and 1.37 M sodium chloride, was from Alfa Aesar (Heysham, UK). Stock TRIS
buffer solution was diluted 10 times for the experiments. All solutions were prepared using Millipore
water having a resistivity higher than 18.2 MΩ·cm.
2.1. Fabrication of CaCO3 Vaterite Crystals
CaCO3 crystals were synthesized as described with the slight modifications [35]. A 0.33 M solution
of Na2CO3 in water was added to the equal volume of 0.33 M CaCl2 in water and agitated at 650 rpm
for 30 s. After mixing the solution was left to crystallize for 10 min. For the washing, the suspension of
the crystals was centrifuged at 1000× g for 3 min and supernatant was removed. CaCO3 was then
washed by resuspension in water followed by re-centrifuging and supernatant extraction. The crystals
were dried in the oven preheated at 70 ◦C for 1–2 h.
2.2. LbL-Based PSS/PDAD Capsule Formation
Dry CaCO3 crystals (10 mg) were suspended in 0.5 mL of NaCl of differing concentration (0.05 M,
0.3 M, and 0.1 M). Once suspended in solution, 1 mL of 2 mg·mL−1 PSS (dissolved in the NaCl
solution with respective concentration 0.05 M, 0.3 M, or 0.1 M) was added to the suspension of calcium
carbonate cores. The cores were incubated and shaken in this mixture for 3 min, 10 min or 20 min
following by centrifugation at 1000× g for 3 min. The supernatant was then removed and the particles
were washed twice with 1.5 mL of NaCl solution with respective concentration, re-suspended and
centrifuged under the same conditions. For addition of the second polymer layer, PDAD, the same
process as for the PSS layer was sequentially repeated. The capsules with n = 1 to 6 number of layers
have been fabricated. Crystals coated with polyelectrolyte layers have been analyzed at the same day
as multilayers have been prepared.
CaCO3 cores has been removed by dissolution in 0.2 M EDTA (with the pH adjusted to 7.4) prior
to the loading with R6G and further analysis.
2.3. Postloading of PSS/PDAD Capsules
Suspension of the capsules containing approximately 103–104 capsules (estimated based on the
average capsule size and assuming the 100% yield for both core fabrication and capsule formation)
was incubated with R6G (final concentration 0.1–8 µM) for 30 min and the imaging of the capsules has
been performed directly in the presence of R6G in the supernatant.
2.4. Fluorescence Microscopy
Analysis of the microparticles prepared in this study was carried out using fluorescence
microscopy (EVOS FL, Thermo Fisher Scientific, Waltham, MA, USA). The imaging was performed by
keeping imaging parameters (acquisition time, laser power, magnification) constant. The excitation
wavelength used was 530 nm.
2.5. R6G Binding to PSS, PDAD and Their Complex in the Solution
For the first set of experiments, aqueous solution of R6G was rapidly added to water or PSS or
PDAD dissolved in water. Final concentration of R6G varied in the range of 0.2 to 2 mM while polymer
concentration was fixed at 0.10 mg·mL−1 for PSS and 0.08 mg·mL−1 for PDAD. For the second set
of experiments, 0.5 mM·R6G was rapidly added to pre-formed PSS/PDAD complex (mass ratio 1:1,
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PSS concentration 0.04–0.2 mg·mL−1 or different mass ratios for 0.1 mg·mL−1 PSS). After intensive
shaking for 1 min, all samples have been filtrated using Amicon Ultra-0.5 with ultracel-3 Membrane
(Merck Millipore, Darmstadt, Germany) with a threshold of 3 kDa by centrifugation at 15,000× g
for 20 min. The supernatants were collected and transferred to 25 mM TRIS buffer solution pH
7.4 containing 137 mM NaCl for the measurements. Absorbance spectra have been recorded from
2 µL drops of non-diluted samples using NanoDrop One Microvolume UV–Vis Spectrophotometer
(Thermo Fisher Scientific). Measurements were performed in triplicates.
2.6. Characterization of the Crystals and Microcapsules
Analysis of the morphology of vaterite crystals microcapsules prepared in this study was carried
out using scanning electron microscopy (SEM, Zeiss DSM 40, Goettingen, Germany). CaCO3 crystals
and (PSS/PDAD)2PSS capsules were dried and analyzed by light optical microscopy (EVOS FL,
Thermo Fisher Scientific) on the same day.
3. Results and Discussion
3.1. CaCO3 Templates: Internal Structure
Vaterite microcrystals were obtained by conventional method of mixing equimolar solutions of
CaCl2 and Na2CO3. According to SEM images (Figure 1a), dried crystals had spherical shape with
a diameter of 8.6 ± 3.5 µm (n = 50). The pore size in the microspheres prepared by similar procedure
has previously been reported [36] and was found to be in the range of 5 to 40 nm. The crystals
have highly developed internal structure having total surface area of about 10 m2·g−1 [37]. Herein,
porous internal structure of vaterite crystals is evidenced by the SEM imaging of the broken crystals
(Figure 1b). The channel-like structure of interconnected pores inside CaCO3 crystals allows them to
host an enormous amount of encapsulates or, in the same way, to fill the crystals with a polymeric
matrix [31,38–40].
Figure 1. SEM images of CaCO3 vaterite crystals (a) demonstrating internal structure of the broken
crystal (b).
3.2. Formation of PSS/PDAD Capsules
The well-investigated polyelectrolyte pair of PSS and PDAD (Figure 2) has been used to prepare
multilayer capsules. For all the experiments, PSS has been used as a first layer. Sequential polymer
deposition has been followed by the dissolution of CaCO3 core by the addition of 0.2 M EDTA.
Figure 3 shows the light transmittance images of CaCO3 crystals coated with (PSS/PDAD)2/PSS
multilayers during core dissolution in real time. The crystals of a larger size have been used for this
experiment for the purpose of better visualization.
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Figure 2. Chemical formulae of R6G and polyelectrolytes (poly(styrene-sulfonate) (PSS),
poly(diallyldimethylammonium chloride) (PDAD)) used in this study.
Figure 3. (a) Optical images of capsule formation via addition of 0.2M EDTA solution to CaCO3 crystals
coated with (PSS/PDAD)2/PSS multilayers. The images follow a chronological order from 1 to 4 with
30 s interval and (b) optical image of dried (PSS/PDAD)2/PSS capsules.
First, we focused on capsule stability and an internal structure. The investigation of the stability
of the crystals coated with different number of PSS/PDAD layers allowed us to reveal the optimal
conditions for the formation of the microcapsules (Figure 4). It is known that storage of the vaterite
crystals in water for long time (overnight or more) results in recrystallization of vaterite to more
stable calcite polymorph [41]. Calcite crystals have typical cubic shape that allows to easy distinguish
them from spherical vaterite crystals. Uncoated vaterite crystals undergo complete recrystallization to
calcite while stored overnight (Figure 4b,c). We found that the degree of recrystallization of vaterite
crystals significantly dropped down for three or more deposited polymer layers (Figure 4a). This can
be explained by stabilization of the crystals coated with multilayers, similar effect was observed for
capsules made of PSS and poly(allylamine hydrochloride (PAH) [42].
Figure 3b shows more detailed morphology of (PSS/PDAD)2/PSS capsules. Apparently,
the capsules have a relatively smooth morphology since the capsules appear rather uniform and
flat upon drying. Despite visual flattening, the capsules are usually not hollow inside but have
a polymer complex in the internal lumen due to permeation of polymers through crystal pores during
the LbL coating procedure [1,2]. The complex can affect capsule properties.
An increase of the number of layers (from three to six) led to the strengthening of the capsule shell
that resulted in less prominent capsule shrinkage during core dissolution (Figure 4d). The shrinkage
takes place due to annealing the polymer structure into the formed capsules. This annealing is driven
by closure of some voids between polymers in order to create more ionic pairs in the polymer complex.
As an example, images of CaCO3 crystals coated with three polymer layers before and after addition
of 0.2 M EDTA are shown in Figure 4e,f. The more layers deposited, the more pronounced is the
shrinkage (Figure 4d); most probably this can be explained by the following. There is more filling the
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pores with polymer complex for higher numbers of deposited layers. The polymer complex restricts
physically the shrinkage of the capsules. The effect of the shrinkage can be completely eliminated for
the capsules formed by more than five layers, however, in this case the dissolution of the core required
significantly longer time (Figure 4d). Altogether, these results suggest that the optimal PSS/PDAD
capsules templated on the CaCO3 cores are assembled from four or five layers.
Interestingly, CaCO3-templated PSS/PDAD capsules appear to possess better mechanical stability
compared to those templated on other cores, e.g., melamine formaldehyde [38]. It is also of note
that PSS/PDAD capsules prepared in this study were not prone to the swelling as it was previously
demonstrated for PSS/PDAD melamine formaldehyde-templated capsules of a similar size [39].
This can be explained by low osmotic pressure generated inside the capsules during the core dissolution
step because of a quick release of ions of the dissolved CaCO3 core.
The results described above allow us to assume that the formed polymeric matrix inside CaCO3
template should remain its structure after the elimination of the core. However, the structure may be
affected by shrinkage which cannot be avoided, however, a small amount of shrinkage for capsules
with four and five layers can be accepted and an influence of the layer number can thus be studied.
Staining of the capsules with the dye having high affinity to one of the polymers used, i.e., PSS,
could help identify the distribution of polymers within the capsule interior. This approach will be
further used. It is noninvasive and is based on binding of a fluorescent probe R6G (Figure 2) to free
permanent charges on the PSS backbone. Such an approach first requires a quantitative analysis of PSS
interaction with the fluorescent dye. These issues are further considered in the next two sections.
Figure 4. (a) Degree of the recrystallization as a percentage of calcite crystals for CaCO3 vaterite crystals
coated with different number of PSS/PDAD layers after storage in TRIS buffer overnight. Error bars
are standard deviations (SD) for n = 3 samples. (b,c): Optical images of freshly prepared uncoated
CaCO3 crystals (b) and these crystals stored in TRIS buffer overnight (c). (d) Time required for the
dissolution of CaCO3 core by the addition of 0.2 M EDTA and degree of the shrinkage of PSS/PDAD
capsules composed of different number of layers. Error bars are SD (calculated for at least 10 capsules).
(e,f): CaCO3 crystals coated with (PSS/PDAD)/PSS layers before (e) and after 5 min of incubation with
0.2 M EDTA (f). Scale bars are 10 µm.
3.3. Fluorescence of R6G in the Presence of PSS and PDAD
One of the most common and well-studied fluorescent dyes, R6G (Figure 2), has been chosen
here as a marker to understand the polymer distribution inside the polymer capsules. R6G is known
to have high affinity to PSS due to hydrophobic interactions as well as ionic contacts between R6G
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and PSS. Besides this, the R6G molecule has a small size (MW 442) and a high diffusion coefficient of
~4.3 × 10−10 m2·s−1 [43] that eliminates diffusional limitations and allows the post-loading of capsules
with this dye. This made R6G an ideal candidate for the task above.
Prior to the investigation of the interaction of R6G with the polymer complex, the molecular
complexes of R6G with both capsule components, PSS and PDAD, have been formed and studied.
Figure 5a shows the spectra of free R6G and its complexes with PDAD and PSS: yellow, red,
and gray lines, respectively. Concentrations of 0.10 mg·mL−1 for PSS and 0.08 mg·mL−1 for PDAD
correspond to 0.5 mM of polymer monomer units (MW of the monomers is 206 for sodium salt of
PSS and 162 for PDAD). This allowed the formation of equimolar complex of 0.5 mM R6G with both
polymers. The measurements were performed in TRIS buffer solution pH 7.4 containing 137 mM
NaCl, the same medium as used for capsule fabrication. The wavelengths for maximum adsorption
of a monomer and a dimer were found to be 533 nm and 500 nm, respectively. This is insignificantly
lower than those values reported for R6G dissolved in water (526 nm for a monomer and 498 nm for
a dimer) [44] that may be explained by the use of TRIS-buffer in our study. The addition of PDAD
does not lead to any significant changes in R6G spectrum, while the strong attraction of R6G to PSS
backbone resulted in the shift of the whole absorbance spectra towards longer wavelengths and the
reversal of intensity for the monomer and dimer adsorption maxima. Further elimination of R6G
bound to PSS via ultracentrifugation allows retrieving the shape of initial R6G spectrum (Figure 5a,
black line).
Figure 5. (a) Absorbance spectra of R6G (i) in absence of polymers; (ii) in presence of PDAD; (iii) in
presence of PSS; and (iv) after incubation with PSS that was further removed by ultracentrifugation.
(b) Concentration dependence of 10 mM absorbance of freeR6G at 533 nm, R6G in presence of PDAD
and after incubation with PSS that was further removed by ultracentrifugation. Twenty-five millimolar
TRIS buffer solution pH 7.4 containing 137 mM NaCl was used as a solvent.
The linear dependence of R6G absorbance at its maximum on the dye concentration (Figure 5b)
was found for the range up to approximately 1 mM for both, free R6G and R6G in the presence of
PDAD. Further increase of R6G concentration is most likely associated with R6G self-quenching and
consequent deviation from the linear law [45]. Keeping in mind the shift of the maxima in the spectra
of R6G bound to PSS, the PSS-R6G complex was separated from free R6G by ultracentrifugation prior
to the measurements. In contrast to PDAD, the addition of PSS resulted in binding of all R6G molecules
for the concentration up to 1 mM. For the concentration of R6G higher than 1 mM, linear dependence
with the same slope as for free R6G has been constructed with linear coefficients 3.2 ± 0.4 for R6G/PSS
and 3.9 ± 0.3 for R6G (Figure 5b). This can be explained by the saturation of all PSS binding cites
by R6G at polymer:R6G molar ratio of approximately 1:2. Taking into account the reversal of the
monomer and dimer maxima observed for the R6G-PSS complex (Figure 5a), it can be assumed that
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the interaction of R6G with PSS leads to its dimerization. This is in agreement with previously reported
findings for R6G [46,47] and other dyes of a similar structure [48].
3.4. Interaction of R6G with PSS-PDAD Complex and Multilayers
One can assume that R6G and PDAD may compete for binding to the PSS molecule and therefore
the loading of PSS/PDAD multilayers with R6G may cause the weakening of interpolymer interaction
and affect the structure of multilayer capsules. In order to probe and compare the force of R6G-PSS
and PDAD-PSS interaction, firstly, R6G was added to pre-formed polymer complex of a varied
concentration (Figure 6a). The complex was formed at PSS:PDAD mass ratio of 1:1. Apparently,
the linear decrease of free R6G concentration in solution (R2 = 0.974) in the contact with polymer
complex can be explained by quantitative binding of R6G to free binding sites of PSS. Importantly,
it appears that R6G does not destroy or interpose the pre-formed PSS/PDAD complex which is
also evidenced by the linearity of the observed concentration curve (Figure 6a). For the second set
of experiments, the addition of R6G to PSS/PDAD complex, formed for different polymer ratios
(Figure 6a), also revealed linear dependence of the amount of bound R6G from the free binding sites of
PSS that reaches the saturation when all PSS binding sites are occupied by PDAD.
This obviously indicates the anchorage of R6G to free PSS binding sites. Importantly, it seems that
the equilibrium in in the interaction between R6G, PSS, and PDAD is shifted towards the formation of
the polyelectrolyte complex PSS-PDAD. Therefore, the addition of R6G to the pre-formed PDAD-PSS
complex does not lead to disintegration of the latest. This gives us the possibility to use R6G as
a marker for staining of PSS inside the PSS/PDAD multilayers.
In contrast to polymer complex, polyelectrolyte multilayers templated on vaterite cores consist of
unknown amount of polymers. Because of this, the concentration of R6G to be used for the staining of
the capsules required adjustment. Figure 6a shows the dependence of fluorescence signal accumulated
inside the capsules on the concentration of R6G solution in the contact with them. Similarly to R6G
interaction with polymer complex in solution, the increase of R6G concentration leads to the increase of
fluorescent signal accumulated in the capsules (Figure 6b). This is also accompanied by the increase of
background fluorescence. Rapid accumulation of fluorescence in the capsules is followed by the plateau
that corresponds to the region of saturation of the capsules with R6G. Herein that is also of worth
to note that self-quenching of R6G fluorescence is not likely at this concentration range (Figure 5b).
Based on these results, an R6G concentration of 8 µM has been chosen for further experiments.
Figure 6. (a) Concentration of free R6G in the solution after incubation with the PSS-PDAD
complex (the complex was further removed by ultracentrifugation) as a function of concentration of
PSS-PDAD complex (PSS:PDAD mass ratio 1:1)—blue axis—and as a function of PDAD:PSS mass
ratio (PSS concentration of 0.1 mg·mL−1)—red axis. (b) Cumulative fluorescence of the capsules
(black circles) and background fluorescence (empty circles) as a function of initial concentration of R6G
added to the suspension of (PSS/PDAD)2/PSS capsules. SD are given for n = 4.
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3.5. Imaging of the Internal Capsule Structure
Using the approach developed above, pre-formed PSS/PDAD multilayer capsules were
postloaded with R6G and their internal structure has been investigated via fluorescence imaging
as described in Figure 7. Capsules were characterized by (i) shell thickness calculated as a width at
half-peak height and (ii) capsule filled volume (red filled area). To estimate the latest, two fluorescence
peaks of the capsule shell were fitted with two Gaussian functions (gray line) and their total area was
subtracted from the total area under the profile and correlated with the maximum capsule volume
(yellow filled area).
Figure 7. (a) Fluorescence images of (PSS/PDAD)2/PSS capsules postloaded with R6G. (b) Typical
mathematical treatment of the fluorescence profile depicted as a white line in (a) and taken across
the capsule.
The effect of the last layer in polymer deposition sequence has further been studied to understand
the capsule formation mechanism. (PSS/PDAD)2 and (PSS/PDAD)2/PSS capsules have been
assembled on 15± 5 µm (n = 40) crystals and had the same size of 14± 2 µm (n = 40). The deposition of
PSS as the last layer resulted in the saturation of the whole capsule with PSS that is evidenced by more
than two times higher cumulative fluorescence of (PSS/PDAD)2/PSS capsules while compared with
(PSS/PDAD)2 (Figure 8a,b). Interestingly, this did not affect the overall distribution of PSS: the filled
volume was found to be (47 ± 1)% for (PSS/PDAD)2/PSS capsules and (46 ± 5)% for (PSS/PDAD)2
capsules prepared under the same conditions (Figure 8c). The only explanation can be that both
polymers can permeate inside the pores of the crystals and form a polymer matrix. At the same time,
up until five deposited layers, multiple polymer deposition of polymer molecules is accompanied by
their spontaneous redistribution between the capsule interior matrix and the capsule shell. More layers
deposited may create diffusion limitations that will reduce an increment in the densification of the
internal matrix and make the shell thicker.
Figure 9 shows the schematic structure of the capsules based on the results of the analysis of the
staining profiles. PSS/PDAD multilayers form the shell of the capsule and the internal matrix inside
the capsule. For the low filling of the capsule interior with polymeric matrix, the capsules are expected
to behave as a semipermeable barrier. In this case, the capsule can be assumed as a hollow sphere and
the shell of the capsule is supposed to play a role of a membrane that regulates transport and release
of encapsulated drugs. The synthesis and release kinetics studies for this type of capsules have been
reported, for instance, for chitosan/alginate CaCO3-templated capsules [49] or PAH/PSS capsules
templated on nanoporous anodic alumina [50]. On the other hand, the filling of the capsules with the
polymer leads to the formulation of filled (matrix-type) capsules. Matrix capsules are typically prone
to a different release mechanism that is mostly determined by the composition and internal molecular
structure of the matrix [22]. Some examples include poly(L-glutamic acid)/chitosan microcapsules
templated on melamine formaldehyde [51], chitosan/alginate capsules built up on liposomes [52],
or carrageenan/chitosan capsules deposited onto oil nanoemulsion droplets [53].
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Figure 8. Fluorescence images of (a) (PSS/PDAD)2/PSS and (b) (PSS/PDAD)2 capsules stained with
R6G under the same conditions. (c) Fluorescence profiles across the capsules show the distribution of
R6G (correspond to yellow lines in (a,b)).
Figure 9. The scheme of the structure of PSS/PDAD multilayer capsule stained with R6G. PSS and
PDAD molecules form internal matrix and the shell of the capsule. R6G binds to backbones of the
PSS molecules.
3.6. How to Adjust Capsule Internal Structure?
In order to better understand the mechanism of the formation of a polymer matrix in the capsule
and to evaluate factors that can affect the internal structure of the capsules, the effect of the preparation
conditions on the distribution of PSS inside the capsules was investigated.
First, the effect of ionic strength has been studied (Figure 10a,b). The increase of NaCl
concentration in the medium during capsule formation resulted in the thickening of the capsule
shell (Figure 10a) whereas the filled volume remained the same (Figure 10b). Previously it has been
shown that shell thickening leads to the deceleration of the drug release from core-shell polyelectrolyte
capsules [54,55].
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Figure 10. The influence of the ionic strength in the incubation media (a,b) and deposition time for
each polymer layer (c,d) on (PSS/PDAD)2/PSS capsule shell thickness and filled volume. Error bars
are SD for at least n = 3. * indicates statistical difference of the values (p < 0.95).
On the contrary, deposition time for each polymer step influences the amount of PSS loaded inside
vaterite templates (Figure 10d), while the thickness of the capsule wall is not affected (Figure 10c).
It seems that the increase of the deposition time allows PSS of the first deposition layer to diffuse deeper
inside the crystals and to form the polymer matrix. At the same time, the formation of PSS/PDAD
multilayers requires less time that the diffusion of PSS inside the core, therefore polyelectrolyte
complex is formed on the crystal surface at shorter times and the shell thickness is not affected by
variation of the deposition time. Formulation of a densely packed polyelectrolyte networks results in
reduction in the cumulative release rate due to strong electrostatic interactions as it has been shown
for liposome-templated capsules [53].
The combination of two approaches to vary capsule shell thickness and polymer filling ratio
presented in Figure 10 will further allow to control the structure of PSS/PDAD capsules. This is an
important step in the understanding of the mechanism of capsule formation and will help to tune
release profiles from drug-loaded capsules that is crucial for biomedical and clinical uses.
4. Conclusions
This study demonstrated development of novel approaches for the investigation of internal
structure of polyelectrolyte capsules based on nondestructive postloading with fluorescent probes.
The fabrication of PSS/PDAD capsules composed from different number of layers was described in
terms of capsule mechanical stability assessed by the degree of recrystallization of vaterite CaCO3 and
the changes of the capsule volume (the effect of shrinkage) during core elimination. The structure
of PSS/PDAD capsules templated onto vaterite CaCO3 crystals has been investigated. It was shown
that polymers partially penetrate in the internal pores of vaterite cores and are not liberated after core
removal forming internal matrix of the capsule.
The internal structure of PSS/PDAD capsules can easily be controlled by varying the conditions
of polymer deposition. The increase of ionic strength of surrounding medium during LbL deposition
results in the thickening of the capsule shell while the structure of internal PSS matrix remains
unaffected. On the other hand, the increase of the time of polymer deposition allows polymer
molecules to better fill in the internal pores of CaCO3 core and to form more polymer matrix in the
capsule after the core removal. This is not accompanied by any changes in the thickness of the capsule
wall. Taking together, these two approaches can be successfully applied to further tune the structure of
the capsules.
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The results of this study may open new perspectives to control and pre-program release rate
and profile that is essential for further utilization of multilayer capsules as drug delivery carriers.
In addition, this approach can be transferred to planar multilayers in order to better understand their
growth mechanism and transport through such highly charged systems [56]. This staining approach
can be used to adjust properties of the multilayers to be employed as mimics of the extracellular matrix
and as carriers for hosting bioactives and delivery of bioactives to cells as actively studied in our
laboratory [57–59].
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